Most uncomplicated malaria dominated countries have embraced the recommended first-line treatment of uncomplicated malaria. Artemisinin-based combination therapies such as Artemether-Lumefantrine, Artesunate + Amodiaquine and Dihydroartemisinin-Piperaquine have shown to be effective with Artemether-Lumefantrine and considered the most effective and approved by WHO. The study collected and reviewed recent randomized controlled trials for the treatment of uncomplicated malaria under five children. Eligibility criteria for the selected studies were based on the use of tools such as PICO (T) and data extraction tools such as REPOSE guidelines, PRISMA statement and eligibility criteria. This study includes only RCTs on the treatment of uncomplicated malaria under 5 s. Data was analyzed through comparative-narrative analysis. This study found 8 studies. Selected studies had a total of 10,682 participants within the age range of 0 - 59 months with the diagnosis of uncomplicated malaria and an MCP range of 2000 - 200,000 treated with different antimalarial drugs. Artesunate + Amodiaquine and Dihydroartemisinin-Piperaquine and Artemether-Lumefantrine drugs were found to be consistent in the treatment of uncomplicated malaria under 5 s within three days. Findings show that Artemether-Lumefantrine, Artesunate + Amodiaquine and Dihydroartemisinin-Piperaquine were the best drugs of choice due to their fast rate in fever reduction and parasite clearance. The efficacy of Artesunate + Amodiaquine and Dihydroartemisinin-Piperaquine is comparable to Dihydroartemisinin-Piperaquine. The study concludes that Artesunate + Amodiaquine and Dihydroartemisinin-Piperaquine can also be drugs of choice along with the well-known and utilized Artemether-Lumefantrine combination because of the fever reduction and parasite clearance within the first three days duration.
WHO (2010) World Malaria Report 2010. WHO, Geneva. https://www.who.int/malaria/world_malaria_report_2010
WHO (2013) Implementation of General Assembly Resolution 66/289 on Consolidating Gains and Accelerating Efforts to Control and Eliminate Malaria in Developing Countries, Particularly in Africa, by 2015. Report of the Director General of the World Health Organization.
The Federal Ministry of Health (2012) Roll Back Malaria Partnership: Progress and Impact Series. Country Reports, Number 4, April 2012.
WHO (2012) World Health Statistics 2012: Indicator Compendium. WHO, Geneva.
National Population Commission (2009) Nigeria Demographic and Health Survey 2008. Abuja.
Nubé, M. and Sonneveld, B.G. (2005) The Geographical Distribution of Underweight Children in Africa. Bulletin of the World Health Organization, 83, 764-770.
WHO (2009) Global Estimates of Malaria Cases and Deaths in 2008. World Malaria Report: 27.
Rezai, M.S., Enayati, A. and Heamingway, J. (2013) Malaria in Children, Prospects and Challenges. Journal of Pediatrics Review, 1, 19-24.
Plucinski, M.M., Talundzic, E., Morton, L., Dimbu, P.R., Macaia, A.P., Fortes, F., Udhayakumar, V., et al. (2015) Efficacy of Artemether-Lumefantrine and Dihydroartemisinin-Piperaquine for Treatment of Uncomplicated Malaria in Children in Zaire and Uíge Provinces, Angola. Antimicrobial Agents and Chemotherapy, 59, 437-443. https://doi.org/10.1128/AAC.04181-14
Dahlstrom, S., Aubouy, A., Maiga-Ascofaré, O., Faucher, J.F., Wakpo, A., Ezinmègnon, S., Houzé, S., et al. (2014) Plasmodium falciparum Polymorphisms Associated with ex Vivo Drug Susceptibility and Clinical Effectiveness of Artemisinin-Based Combination Therapies in Benin. Antimicrobial Agents and Chemotherapy, 58, 1-10. https://doi.org/10.1128/AAC.01790-12
WHO (2014) Malaria: From Malaria Control to Malaria Elimination: A Manual for Elimination Scenario Planning April 2014. http://www.who.int/malaria/publications/atoz/9789241507028/en
Crowther, M., Lim, W. and Crowther, M.A. (2010) Systematic Review and Meta-Analysis Methodology. Blood, 116, 3140-3146. https://doi.org/10.1182/blood-2010-05-280883
Higgins, J.P., Altman, D.G., Gotzsche, P.C., Jüni, P., Moher, D., Oxman, A.D., Sterne, J.A., et al. (2011) The Cochrane Collaboration’s Tool for Assessing Risk of Bias in Randomised Trials. British Medical Journal, 343, 5928-5931. https://doi.org/10.1136/bmj.d5928
Higgins, J.P. and Green, S. (2008) Cochrane Handbook for Systematic Reviews of Interventions. John Wiley & Sons, Chichester. https://doi.org/10.1002/9780470712184
Moher, D., Hopewell, S., Schulz, K.F., Montori, V., Gotzsche, P.C., Devereaux, P.J., Altman, D.G., et al. (2010) CONSORT 2010 Explanation and Elaboration: Updated Guidelines for Reporting Parallel Group Randomised Trials. Journal of Clinical Epidemiology, 63, 1-37. https://doi.org/10.1016/j.jclinepi.2010.03.004
Higgins, J., Ramsay, C., Reeves, B. C., Deeks, J.J., Shea, B., Valentine, J.C., Wells, G., et al. (2013) Issues Relating to Study Design and Risk of Bias When Including Non-Randomized Studies in Systematic Reviews on the Effects of Interventions. Research Synthesis Methods, 4, 12-25. https://doi.org/10.1002/jrsm.1056
Nazroo, J.Y. (2006) Health and Social Research in Multiethnic Societies. Routledge, New York. https://doi.org/10.4324/9780203969939
Lown, C., Sierra, T. and Boyer, J. (2013) How Users Search the Library from a Single Search Box. College & Research Libraries, 74, 227-241. https://doi.org/10.5860/crl-321
Yang, S.Q. and Hofmann, M.A. (2013) The Next Generation Library Catalog: A Comparative Study of the OPACs of Koha, Evergreen, and Voyager. Information Technology and Libraries, 29, 141-150. https://doi.org/10.6017/ital.v29i3.3139
Kristjansson, E., Francis, D.K., Liberato, S., Benkhalti Jandu, M., Welch, V., Batal, M., Petticrew, M., et al. (2012) Feeding Interventions for Improving the Physical and Psychosocial Health of Disadvantaged Children Aged Three Months to Five Years. Cochrane Database of Systematic Reviews, No. 6, CD009924. https://doi.org/10.1002/14651858.CD009924
Higgins, J.P. (2008) Cochrane Handbook for Systematic Reviews of Interventions (5). Wiley-Blackwell, Chichester. https://doi.org/10.1002/9780470712184
Pahor, M. and Cesari, M. (2012) Study Design: Randomized Controlled Trials. In: The Epidemiology of Aging, Springer, Berlin, 27-47. https://doi.org/10.1007/978-94-007-5061-6_3
Bell, M.L., Kenward, M.G., Fairclough, D.L. and Horton, N.J. (2013) Differential Dropout and Bias in Randomised Controlled Trials: When It Matters and When It May Not. BMJ: British Medical Journal, 346, 8668. https://doi.org/10.1136/bmj.e8668
Gurusamy, K.S., Gluud, C., Nikolova, D. and Davidson, B.R. (2009) Assessment of Risk of Bias in Randomized Clinical Trials in Surgery. British Journal of Surgery, 96, 342-349. https://doi.org/10.1002/bjs.6558
Higgins, J.P.T. and Altman, D.G. (2008) Assessing Risk of Bias in Included Studies. In: Higgins, J.P.T. and Green, S., Eds., Cochrane Handbook for Systematic Reviews of Interventions, Wiley, Hoboken, 187-241. https://doi.org/10.1002/9780470712184.ch8
Hopewell, S., Clarke, M., Lusher, A., Lefebvre, C. and Westby, M. (2002) A Comparison of Hand-Searching versus MEDLINE Searching to Identify Reports of Randomized Controlled Trials. Statistics in Medicine, 21, 1625-1634. https://doi.org/10.1002/sim.1191
Buscemi, N., Hartling, L., Vandermeer, B., Tjosvold, L. and Klassen, T.P. (2006) Single Data Extraction Generated More Errors than Double Data Extraction in Systematic Reviews. Journal of Clinical Epidemiology, 59, 697-703. https://doi.org/10.1016/j.jclinepi.2005.11.010
Liberati, A., Altman, D.G., Tetzlaff, J., Mulrow, C., Gotzsche, P.C., Ioannidis, J.P., Moher, D., et al. (2009) The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Healthcare Interventions: Explanation and Elaboration. Annals of Internal Medicine, 151, 65. https://doi.org/10.7326/0003-4819-151-4-200908180-00136
Eccles, M.P., Weijer, C. and Mittman, B. (2011) Requirements for Ethics Committee Review for Studies Submitted to Implementation Science. Implementation Science, 6, 32. https://doi.org/10.1186/1748-5908-6-32
Kalichman, M.W. (2011) Overview: Underserved Areas of Education in the Responsible Conduct of Research: Authorship. Science and Engineering Ethics, 17, 335-339. https://doi.org/10.1007/s11948-011-9281-3
Wager, E. and Wiffen, P.J. (2011) Ethical Issues in Preparing and Publishing Systematic Reviews. Journal of Evidence-Based Medicine, 4, 130-134. https://doi.org/10.1111/j.1756-5391.2011.01122.x
Four Artemisinin-Based Combinations (4ABC) Study Group (2011) A Head-to-Head Comparison of Four Artemisinin-Based Combinations for Treating Uncomplicated Malaria in African Children: A Randomized Trial. PLoS Medicine, 8, e1001119. https://doi.org/10.1371/journal.pmed.1001119
Yeka, A., Tibenderana, J., Achan, J., D’Alessandro, U. and Talisuna, A.O. (2013) Efficacy of Quinine, Artemether-Lumefantrine and Dihydroartemisinin-Piperaquine as Rescue Treatment for Uncomplicated Malaria in Ugandan Children. PLoS ONE, 8, 53772-53775. https://doi.org/10.1371/journal.pone.0053772
Kapisi, J., Bigira, V., Clark, T., Kinara, S., Mwangwa, F., Achan, J., Dorsey, G., et al. (2015) Efficacy and Safety of Artemether-Lumefantrine for the Treatment of Uncomplicated Malaria in the Setting of Three Different Chemopreventive Regimens. Malaria Journal, 14, Article No. 53. https://doi.org/10.1186/s12936-015-0583-9
Faye, B., Ndiaye, J.L., Tine, R., Sylla, K., Gueye, A., Lo, A.C. and Gaye, O. (2010) A Randomized Trial of Artesunate Mefloquine versus Artemether Lumefantrine for the Treatment of Uncomplicated Plasmodium falciparum Malaria in Senegalese Children. The American Journal of Tropical Medicine and Hygiene, 82, 140-144. https://doi.org/10.4269/ajtmh.2010.09-0265
Maiga, H., Djimde, A.A., Beavogui, A.H., Toure, O., Tekete, M., Sangare, C.P.O., Doumbo, O.K., et al. (2015) Efficacy of Sulphadoxine-Pyrimethamine+ Artesunate, Sulphadoxine-Pyrimethamine+ Amodiaquine, and Sulphadoxine-Pyrimethamine Alone in Uncomplicated Falciparum Malaria in Mali. Malaria Journal, 14, 64-71. https://doi.org/10.1186/s12936-015-0557-y
Nambozi, M., Van Geertruyden, J.P., Hachizovu, S., Chaponda, M., Mukwamataba, D., Mulenga, M., D’Alessandro, U., et al. (2011) Safety and Efficacy of Dihydroartemisinin-Piperaquine versus Artemether-Lumefantrine in the Treatment of Uncomplicated Plasmodium falciparum Malaria in Zambian Children. Malaria Journal, 10, Article No. 50. https://doi.org/10.1186/1475-2875-10-50
Schramm, B., Valeh, P., Baudin, E., Mazinda, C.S., Smith, R., Pinoges, L., Guérin, P.J., et al. (2013) Tolerability and Safety of Artesunate-Amodiaquine and Artemether-Lumefantrine Fixed Dose Combinations for the Treatment of Uncomplicated Plasmodium falciparum Malaria: Two Open-Label, Randomized Trials in Nimba County, Liberia. Malaria Journal, 12, Article No. 250. https://doi.org/10.1186/1475-2875-12-250
Whegang, S.Y., Tahar, R., Foumane, V.N., Soula, G., Gwét, H., Thalabard, J.C. and Basco, L.K. (2010) Efficacy of Non-Artemisinin- and Artemisinin-Based Combination Therapies for Uncomplicated Falciparum Malaria in Cameroon. Malarial Journal, 9, Article No. 56. https://doi.org/10.1186/1475-2875-9-56
Faye, B., Offianan, A.T., Ndiaye, J.L., Tine, R.C., Touré, W., Djoman, K., Gaye, O., et al. (2010) Efficacy and Tolerability of Artesunate-Amodiaquine (Camoquin plus®) versus Artemether-Lumefantrine (Coartem®) against Uncomplicated Plasmodium falciparum Malaria: Multisite Trial in Senegal and Ivory Coast. Tropical Medicine & International Health, 15, 608-613. https://doi.org/10.1111/j.1365-3156.2010.02487.x
Fergusson, D., Aaron, S.D., Guyatt, G. and Hébert, P. (2002) Post-Randomisation Exclusions: The Intention to Treat Principle and Excluding Patients from Analysis. BMJ, 325, 652-654. https://doi.org/10.1136/bmj.325.7365.652
Balk, E.M., Bonis, P.A., Moskowitz, H., Schmid, C.H., Ioannidis, J.P., Wang, C. and Lau, J. (2002) Correlation of Quality Measures with Estimates of Treatment Effect in Meta-Analyses of Randomized Controlled Trials. JAMA, 287, 2973-2982. https://doi.org/10.1001/jama.287.22.2973
Siersma, V., Als-Nielsen, B., Chen, W., Hilden, J., Gluud, L.L. and Gluud, C. (2007) Multivariable Modelling for Meta-Epidemiological Assessment of the Association between Trial Quality and Treatment Effects Estimated in Randomized Clinical Trials. Statistics in Medicine, 26, 2745-2758. https://doi.org/10.1002/sim.2752
Sodahlon, Y.K., Agbo, K., Morgah, K., Adjogble, K., Avodagbe, A., Djadou, K.E., Malvy, J.M., et al. (2003) Chloroquine Efficacy in the Treatment of Uncomplicated Malaria at Three Sentinel Sites in Northern Togo. Annals of Tropical Medicine and Parasitology, 97, 775-782. https://doi.org/10.1179/000349803225002471
Ngasala, B.E., Malmberg, M., Carlsson, A.M., Ferreira, P.E., Petzold, M.G., Blessborn, D., Martensson, A., et al. (2011) Efficacy and Effectiveness of Artemether-Lumefantrine after Initial and Repeated Treatment in Children https://doi.org/10.1093/cid/cir066
Gbotosho, G.O., Folarin, O.A., Bustamante, C., da Silva, L.H.P., Mesquita, E., Sowunmi, A., Happi, C.T., et al. (2012) Different Patterns of pfcrt and pfmdr1 Polymorphisms in P. falciparum Isolates from Nigeria and Brazil: The Potential Role of Antimalarial Drug Selection Pressure. The American Journal of Tropical Medicine and Hygiene, 86, 211-213. https://doi.org/10.4269/ajtmh.2012.11-0368
Gbotosho, G.O., Sowunmi, A., Happi, C.T. and Okuboyejo, T.M. (2011) Therapeutic Efficacies of Artemisinin-Based Combination Therapies in Nigerian Children with Uncomplicated Falciparum Malaria during Five Years of Adoption as First-Line Treatments. The American Journal of Tropical Medicine and Hygiene, 84, 936-943. https://doi.org/10.4269/ajtmh.2011.10-0722
WHO (2011) World Malaria Report. https://www.who.int/malaria/world_malaria_report_2011/en
Oguche, S., Okafor, H.U., Watila, I., Meremikwu, M., Agomo, P., Ogala, W., Sowunmi, A., et al. (2014) Efficacy of Artemisinin-Based Combination Treatments of Uncomplicated Falciparum Malaria in Under-Five-Year-Old Nigerian Children. The American Journal of Tropical Medicine and Hygiene, 91, 925-935. https://doi.org/10.4269/ajtmh.13-0248
Chotivanich, K., Udomsangpetch, R., Dondorp, A., Williams, T., Angus, B., Simpson, J.A., White, N.J., et al. (2000) The Mechanisms of Parasite Clearance after Antimalarial Treatment of Plasmodium falciparum Malaria. The Journal of Infectious Diseases, 182, 629-633. https://doi.org/10.1086/315718
Gbotosho, G.O., Okuboyejo, T., Happi, C.T. and Sowunmi, A. (2014) Fall in Hematocrit per 1,000 Parasites Cleared from Peripheral Blood: A Simple Method for Estimating Drug-Related Fall in Hematocrit after Treatment of Malaria Infections. American Journal of Therapeutics, 21, 193-197. https://doi.org/10.1097/MJT.0b013e31822119d9
Rolling, T., Wichmann, D., Schmiedel, S., Burchard, G.D., Kluge, S. and Cramer, J.P. (2013) Artesunate versus Quinine in the Treatment of Severe Imported Malaria: Comparative Analysis of Adverse Events Focussing on Delayed Haemolysis. Malaria Journal, 12, Article No. 241. https://doi.org/10.1186/1475-2875-12-241
Owens, D.C. (2014) A Guide to the Extrapyramidal Side-Effects of Antipsychotic Drugs. Cambridge University Press, Cambridge. https://doi.org/10.1017/CBO9781139149112